Australia seems poised to welcome a groundbreaking treatment for weight issues: Retatrutide. This new dual compound – targeting on both GLP-1 and GIP receptors – has significant efficacy in clinical research, indicating meaningful drops in BMI. While availability is pending with TGA, a number of